Standout Papers

Inactivating mutations of the histone methyltransferase gene EZ... 2002 2026 2010 2018 798
  1. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders (2010)
    Thomas Ernst, Andrew Chase et al. Nature Genetics
  2. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy (2002)
    Andreas Hochhaus, Sebastian Kreil et al. Leukemia

Immediate Impact

12 by Nobel laureates 12 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
Diagnosis and Management of Multiple Myeloma
2022 Standout
7 intermediate papers

Works of Nicholas C.P. Cross being referenced

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
2014
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
2010

Author Peers

Author Last Decade Papers Cites
Nicholas C.P. Cross 11297 8361 6343 6991 387 19.5k
D. Gary Gilliland 12073 9410 3921 12071 144 22.1k
Attilio Orazi 8567 6622 2274 4339 279 15.6k
François Guilhot 14255 10326 6618 2910 347 18.0k
Robert P. Hasserjian 9013 6067 1820 4535 282 15.6k
Oliver G. Ottmann 10174 4907 2719 4850 369 15.8k
William Vainchenker 16522 11579 3355 11725 569 28.7k
Nora Heisterkamp 7270 4828 1885 6601 219 15.0k
Maher Albitar 9011 7994 1339 7419 340 19.6k
Roland Berger 8869 4614 1460 9961 353 18.3k
D. Gary Gilliland 8009 4083 2005 8287 126 15.9k

All Works

Loading papers...

Rankless by CCL
2026